Sage Mountain Advisors LLC Sells 58 Shares of UnitedHealth Group Incorporated $UNH

Sage Mountain Advisors LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the second quarter, Holdings Channel reports. The firm owned 6,265 shares of the healthcare conglomerate’s stock after selling 58 shares during the quarter. Sage Mountain Advisors LLC’s holdings in UnitedHealth Group were worth $1,954,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. DDD Partners LLC purchased a new stake in UnitedHealth Group during the second quarter valued at approximately $7,108,000. Moment Partners LLC increased its stake in shares of UnitedHealth Group by 16.6% in the second quarter. Moment Partners LLC now owns 946 shares of the healthcare conglomerate’s stock worth $295,000 after purchasing an additional 135 shares in the last quarter. Lee Danner & Bass Inc. increased its stake in shares of UnitedHealth Group by 65.9% in the second quarter. Lee Danner & Bass Inc. now owns 19,158 shares of the healthcare conglomerate’s stock worth $5,977,000 after purchasing an additional 7,607 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of UnitedHealth Group by 9.2% in the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,855,717 shares of the healthcare conglomerate’s stock worth $890,898,000 after purchasing an additional 240,664 shares in the last quarter. Finally, MN Wealth Advisors LLC purchased a new stake in shares of UnitedHealth Group in the second quarter worth $290,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $362.78 on Friday. The firm has a 50-day moving average price of $338.43 and a 200-day moving average price of $338.97. The firm has a market capitalization of $328.56 billion, a PE ratio of 15.72, a price-to-earnings-growth ratio of 2.33 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on UNH shares. UBS Group reissued a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. The Goldman Sachs Group assumed coverage on shares of UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 target price for the company. Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Robert W. Baird reiterated an “underperform” rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Finally, Royal Bank Of Canada lowered their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Eighteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $385.13.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.